Table 5.
Haplotype analysis between SLE patients and Healthy controls.
| Haplotype | SLE n (%) | Controls n (%) | χ2 | P values | OR (95% CI) |
|---|---|---|---|---|---|
| CTA | 217.23 (42.8) | 266.00 (34.1) | 9.320 | 0.002 | 1.435 (1.137–1.810) |
| CTC | 4.03 (0.8) | 25.54 (3.3) | 8.557 | 0.003 | 0.234 (0.081–0.674) |
| TCA | 125.43 (24.7) | 164.34 (21.1) | 2.101 | 0.147 | 1.218 (0.933–1.589) |
| TCC | 119.83 (23.6) | 173.21 (22.2) | 0.252 | 0.615 | 1.071 (0.820–1.398) |
| TTA | 27.74 (5.5) | 123.62 (15.8) | 32.701 | 0.001 | 0.303 (0.197–0.465) |
| TTC | 0.00 (0.0) | 20.84 (2.7) | – | – | – |
| CCA | 9.61 (1.9) | 0.04 (0.0) | – | – | – |
| CCC | 4.13 (0.8) | 6.41 (0.8) | – | – | – |
Haplotype comprised rs2296283, rs9943922 and rs7324510.
SLE systemic lupus erythematosus, OR odds ratio, CI confidence interval.